TY - JOUR
T1 - Parity reduces mammary repopulating activity but does not affect mammary stem cells defined as CD24 + CD29/CD49fhi in mice
AU - Dall, Genevieve V.
AU - Vieusseux, Jessica
AU - Seyed-Razavi, Yashar
AU - Godde, Nathan
AU - Ludford-Menting, Mandy
AU - Russell, Sarah M.
AU - Ashworth, Alan
AU - Anderson, Robin L.
AU - Risbridger, Gail P.
AU - Shackleton, Mark
AU - Britt, Kara L.
PY - 2020/10
Y1 - 2020/10
N2 - Background: Breast cancer (BCa) mortality is decreasing with early detection and improvement in therapies. The incidence of BCa, however, continues to increase, particularly estrogen-receptor-positive (ER +) subtypes. One of the greatest modifiers of ER + BCa risk is childbearing (parity), with BCa risk halved in young multiparous mothers. Despite convincing epidemiological data, the biology that underpins this protection remains unclear. Parity-induced protection has been postulated to be due to a decrease in mammary stem cells (MaSCs); however, reports to date have provided conflicting data. Methods: We have completed rigorous functional testing of repopulating activity in parous mice using unfractionated and MaSC (CD24midCD49fhi)-enriched populations. We also developed a novel serial transplant method to enable us to assess self-renewal of MaSC following pregnancy. Lastly, as each pregnancy confers additional BCa protection, we subjected mice to multiple rounds of pregnancy to assess whether additional pregnancies impact MaSC activity. Results: Here, we report that while repopulating activity in the mammary gland is reduced by parity in the unfractionated gland, it is not due to a loss in the classically defined MaSC (CD24+CD49fhi) numbers or function. Self-renewal was unaffected by parity and additional rounds of pregnancy also did not lead to a decrease in MaSC activity. Conclusions: Our data show instead that parity impacts on the stem-like activity of cells outside the MaSC population.
AB - Background: Breast cancer (BCa) mortality is decreasing with early detection and improvement in therapies. The incidence of BCa, however, continues to increase, particularly estrogen-receptor-positive (ER +) subtypes. One of the greatest modifiers of ER + BCa risk is childbearing (parity), with BCa risk halved in young multiparous mothers. Despite convincing epidemiological data, the biology that underpins this protection remains unclear. Parity-induced protection has been postulated to be due to a decrease in mammary stem cells (MaSCs); however, reports to date have provided conflicting data. Methods: We have completed rigorous functional testing of repopulating activity in parous mice using unfractionated and MaSC (CD24midCD49fhi)-enriched populations. We also developed a novel serial transplant method to enable us to assess self-renewal of MaSC following pregnancy. Lastly, as each pregnancy confers additional BCa protection, we subjected mice to multiple rounds of pregnancy to assess whether additional pregnancies impact MaSC activity. Results: Here, we report that while repopulating activity in the mammary gland is reduced by parity in the unfractionated gland, it is not due to a loss in the classically defined MaSC (CD24+CD49fhi) numbers or function. Self-renewal was unaffected by parity and additional rounds of pregnancy also did not lead to a decrease in MaSC activity. Conclusions: Our data show instead that parity impacts on the stem-like activity of cells outside the MaSC population.
KW - Breast cancer
KW - Mammary fat pad transplants
KW - Parity
KW - Stem cells
UR - http://www.scopus.com/inward/record.url?scp=85088293452&partnerID=8YFLogxK
U2 - 10.1007/s10549-020-05804-1
DO - 10.1007/s10549-020-05804-1
M3 - Article
C2 - 32696317
AN - SCOPUS:85088293452
VL - 183
SP - 565
EP - 575
JO - Breast Cancer Research and Treatment
JF - Breast Cancer Research and Treatment
SN - 0167-6806
IS - 3
ER -